ZIC2 and small cell lung carcinoma: Autoantibodies in small lung cell carcinoma patients show cross-reactivity among ZIC1, ZIC2, and ZIC4 proteins [15], suggesting that immunoreactivities of the autoantibodies are directed primarily against the conserved zinc finger domains of ZIC [16].